Home › NDC Lookup › Ingredients › Fexofenadine Hydrochloride And Pseudoeph... › 46122-0452-60
⚪image loading
(from DailyMed)

Fexofenadine Hydrochloride and Pseudoephedrine 60 mg; 120 mg Tablet, Film Coated, Extended Release, 20-count — NDC 46122-452-60 (Billing 46122-0452-60)

by AmeriSource Bergen · 1 BLISTER PACK in 1 CARTON / 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

This is a package of 20 tablets of Fexofenadine Hydrochloride and Pseudoephedrine 60 mg; 120 mg Tablet, Film Coated, Extended Release from AmeriSource Bergen, no longer marketed (first marketed Mar 2018), no longer in the FDA NDC Directory. It is this product's only package size.

NDC 46122-0452-60
🏷️ FDA NDC (as labeled) 46122-452-60 billing pads the product segment with a zero
OTC Generic Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 46122-452-60 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
46122 labeler · 452 product · 60 package
Package marketed since
Mar 1, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
20 EA per package
Barcode (UPC-A, from the NDC)
3 4612245260 1
FDA record last changed
Jul 24, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through May 2020. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 46122-452-60
Product NDC 46122-452
11-digit billing NDC 46122045260
NCPDP billing unit EA — each (per item)
RxCUI 997406
UNII 2S068B75ZU, 6V9V2RYJ8N
Application # ANDA090818
SPL Set ID c20f780c-562b-4eb6-940d-2973382118eb
Established class (EPC) Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist
Mechanism of action Adrenergic alpha-Agonists; Histamine H1 Receptor Antagonists
DEA schedule Non-controlled
Marketing category ANDA
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through May 2020)
Marketing start 2018-03-01
Route ORAL
Dosage form TABLET, FILM COATED, EXTENDED RELEASE
Substance FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 43993002687420
GPI class GNP Fexofenadine/PSE ER
GCN Seq No 036868
GCN 63565
HICL code 016846
Ingredient (HICL) Fexofenadine/Pseudoephedrine
HIC1 code Z
Therapeutic class — broad (HIC1) Body As A Whole
HIC2 code Z2
Therapeutic class — intermediate (HIC2) Antihistamines, Antiserotonins, Immunosuppressants
HIC3 code Z2O
Therapeutic class — specific (HIC3) 2Nd Gen Antihistamine And Decongestant Combination
AHFS code 04:08.00.00
AHFS class Second Generation Antihistamines
FDB label name FEXOFENADINE-PSE ER 60-120 TAB
FDB brand name Fexofenadine-Pse Er
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 036868
  • GCN: 63565
  • GPI-14 (Medi-Span): 43993002687420
  • HICL (First Databank): 016846
  • AHFS class code: 04:08.00.00
  • RxCUI (RxNorm): 997406
Why two NDCs? The FDA registers this code as 46122-452-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0452-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Histamine-1 Receptor Antagonist class.

Pharmacologic class Histamine-1 Receptor Antagonist
Drug family (ATC) Other antihistamines for systemic use
How it works Histamine H1 Receptor Antagonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name FEXOFENADINE-PSE ER 60-120 TAB Ingredient Fexofenadine/Pseudoephedrine
📖 What it is MedlinePlus · NLM

The combination of fexofenadine and pseudoephedrine is used to treat allergy or cold symptoms: runny nose sneezing congestion (stuffy nose, sinus pressure) red, itchy, or watery eyes itching of the nose, throat, or roof of the mouth Fexofenadine is in a class of medications called antihistamines. It works by blocking the effects of histamine, a substance in the body that causes allergy symptoms. Pseudoephedrine is in a class of medications called decongestants. It works by causing narrowing of the blood vessels in the nasal passages to relieve congestion.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It actually tackles two things at once. The fexofenadine part is an antihistamine that helps with allergy symptoms like runny nose, sneezing, itchy and watery eyes, and itching of...
  • What exactly does this medication do — does it just help with allergies?
  • Yes, it really does matter. You should take this tablet on an empty stomach with a full glass of water. Also, use water specifically — do not take it with fruit juice. Taking it wi...
  • Does it matter when I take it — like with food or on an empty stomach?
📖 Read our full Fexofenadine and Pseudoephedrine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
46122-0452-60 You're viewing this Main listing 1 BLISTER PACK in 1 CARTON / 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK 2018-03-01 — Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 43598-0823-14 Dr. 5 tablets $0.483 — Availability likely —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 46122-0694-65 AmeriSource 10 tablets $0.483 — Availability likely —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 55111-0447-14 Dr. 5 tablets $0.483 — Availability likely —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00363-0044-20 Walgreens 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00363-0094-67 WALGREEN 10 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 00363-1606-20 Walgreens 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00363-2110-20 walgreens 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 00536-1431-07 Rugby 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 11822-0021-04 Rite 5 tablets — — FDA listed —
Allergy and Congestion 60 mg/1; 120 mg 11822-7388-05 Rite 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 30142-0059-84 KROGER 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 30142-0097-20 Kroger 5 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 30142-0447-14 The 5 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 30142-0611-14 The 5 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 37808-0022-31 HEB 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 37808-0999-30 H 30 tablets — — FDA listed —
Allegra-D Allergy and Congestion 60 mg/1; 120 mg 41167-4310-02 Chattem, 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 41415-0995-20 PUBLIX 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mgthis 46122-0452-60 AmeriSource 20 tablets — — Discontinued —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 47335-0724-64 Sun 5 tablets — — FDA listed —
Allegra-D 60 mg/1; 120 mg 50090-1203-00 A-S 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 51316-0007-67 CVS 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 51316-0015-20 CVS 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 51660-0037-21 Ohm 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 58602-0807-67 Aurohealth 10 tablets — — FDA listed —
Fexofenadine HCl and Pseudoephedrine HCI 60 mg/1; 120 mg 59779-0508-14 CVS 5 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 69842-0973-20 CVS 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 69842-0990-20 CVS 20 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 70000-0677-01 Cardinal 10 tablets — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 70677-1010-01 Strategic 5 tablets — — FDA listed —
Foster And Thrive Allergy And Congestion D 60 mg/1; 120 mg 70677-1315-01 Strategic 1 tablet — — FDA listed —
Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60 mg/1; 120 mg 79903-0108-20 Wal-mart 5 tablets — — FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2018
On the market since
Mar 2018
📍
2026
Currently FDA-listed
8 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmeriSource Bergen
Application holderSUN PHARMACEUTICAL INDUSTRIES LTD
FDA applicationANDA090818 (ANDA)
Labeler code46122
First marketedMar 2018
Product typeHuman Otc Drug
Portfolio206 products on file

More NDCs from AmeriSource Bergen labeler code 46122

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 60 words ▾

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat temporarily relieves nasal congestion due to the common cold, hay fever or other upper respiratory allergies reduces swelling of nasal passages temporarily relieves sinus congestion and pressure temporarily restores freer breathing through the nose

⏱️ Dosage and Administration 73 words ▾

Directions do not divide, crush, chew or dissolve the tablet; swallow tablet whole adults and children 12 years of age and over take 1 tablet with a glass of water every 12 hours on an empty stomach; do not take more than 2 tablets in 24 hours children under 12 years of age do not use adults 65 years of age and older ask a doctor consumers with kidney disease ask a doctor

⚠️ Warnings 1 words ▾

Warnings

📦 Storage and Handling 28 words ▾

Other information safety sealed; do not use if inner safety seal is open or torn store between 20° to 25°C (68° to 77°F) USP dissolution test is pending.

🧪 Active Ingredient 16 words ▾

Active ingredient(s) (in each extended-release tablet) Fexofenadine HCl, USP 60 mg Pseudoephedrine HCl, USP 120 mg

🧪 Inactive Ingredients 28 words ▾

Inactive ingredients colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, ethyl cellulose, ferric oxide yellow, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone, stearic acid.

🎯 Purpose 4 words ▾

Purpose Antihistamine Nasal Decongestant

📄 Do Not Use 76 words ▾

Do not use if you have ever had an allergic reaction to this product or any of its ingredients if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. if you have difficulty swallowing

📄 Ask a Doctor Before Use If 37 words ▾

Ask a doctor before use if you have heart disease thyroid disease glaucoma high blood pressure diabetes trouble urinating due to an enlarged prostate gland kidney disease. Your doctor should determine if you need a different dose.

📄 When Using This Product 30 words ▾

When using this product do not take more than directed do not take at the same time as aluminum or magnesium antacids do not take with fruit juices (see Directions)

📄 Stop Use and Ask a Doctor If 37 words ▾

Stop use and ask doctor if an allergic reaction to this product occurs. Seek medical help right away. symptoms do not improve within 7 days or are accompanied by a fever you get nervous, dizzy, or sleepless

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children In case of overdose, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 87 words ▾

PRINCIPAL DISPLAY PANEL - 60 mg/120 mg Tablet Blister Pack Carton GOOD NEIGHBOR PHARMACY ® Compare to Allegra-D ® active ingredients** NDC 46122-452-60 Original Prescription Strength NON-DROWSY 12 HOUR fexofenadine HCl 60 mg/antihistamine pseudoephedrine HCl 120 mg/nasal decongestant Extended-Release Tablets, USP Indoor & Outdoor Allergies Allergy & Congestion Relief of: Nasal and Sinus Congestion Due to Colds or Allergies Sneezing; Runny Nose; Itchy, Watery Eyes and Itchy Nose or Throat Due to Allergies 20 Extended-Release Tablets PRINCIPAL DISPLAY PANEL - 60 mg/120 mg Tablet Blister Pack Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product No longer marketed (per FDA listing data)
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
AmeriSource Bergen is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 46122-0450-21 · Amerisource 46122-0455-52 · Amerisource →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.